|
|
| Product Name: | ML364 | | Synonyms: | ML364;ML364, 1991986-30-1;ML 364;ML-364;ML364, >98%;Benzamide, 2-[[(4-methylphenyl)sulfonyl]amino]-N-(4-phenyl-2-thiazolyl)-4-(trifluoromethyl)-;ML364 >=98% (HPLC);2-((4-Methylphenyl)sulfonamido)-N-(4-phenylthiazol-2-yl)-4-(trifluoromethyl)benzamide;Deubiquitinase,Inhibitor,ML 364,DUBs,ML-364,ML364,inhibit | | CAS: | 1991986-30-1 | | MF: | C24H18F3N3O3S2 | | MW: | 517.54 | | EINECS: | | | Product Categories: | | | Mol File: | 1991986-30-1.mol |  |
| | ML364 Chemical Properties |
| density | 1.457±0.06 g/cm3(Predicted) | | storage temp. | Inert atmosphere,Store in freezer, under -20°C | | solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS (pH 7.2) (1:2): 0.33 mg/ml; Ethanol: 20 mg/ml | | form | A crystalline solid | | pka | 6.51±0.50(Predicted) |
| | ML364 Usage And Synthesis |
| Uses | ML364 is a small molecular inhibitor of the deubiquitinase USP2, which accelerates cyclin D1 degrdation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma. |
| | ML364 Preparation Products And Raw materials |
|